लोड हो रहा है...
A novel nasal powder formulation of glucagon: toxicology studies in animal models
BACKGROUND: Glucagon nasal powder (GNP), a novel intranasal formulation of glucagon being developed to treat insulin-induced severe hypoglycemia, contains synthetic glucagon (10 % w/w), beta-cyclodextrin, and dodecylphosphocholine. The safety of this formulation was evaluated in four studies in anim...
में बचाया:
| में प्रकाशित: | BMC Pharmacol Toxicol |
|---|---|
| मुख्य लेखकों: | , , , , , , , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
BioMed Central
2015
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4621930/ https://ncbi.nlm.nih.gov/pubmed/26502880 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40360-015-0026-9 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|